Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 039324/0518 | |
| Pages: | 3 |
| | Recorded: | 08/03/2016 | | |
| Attorney Dkt #: | ANGVE-100US5 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15055884
|
Filing Dt:
|
02/29/2016
|
|
Publication #:
|
|
Pub Dt:
|
09/01/2016
| | | | |
|
Title:
|
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLT1 ANTAGONIST FOR TREATING CANCER
|
|
|
Assignee
|
|
|
|
|
| SE-151 85 |
| SODERTALJE, SWEDEN |
|
|
Correspondence name and address
|
| |
MEDIMMUNE, LLC
|
| |
ONE MEDIMMUNE WAY
|
| |
GAITHERSBURG, MD 20878
|
Search Results as of:
05/23/2024 06:48 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
